Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -5.13% is 179% below its 5-year average of 6.46%, around the middle of its 5-year range (-31.35%–24.14%).
46.03% above its 12-month average of -9.51%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -26.46%.
OPERATING MARGIN
-5.13%
OPERATING MARGIN AVG TTM
-9.51%
OPERATING MARGIN AVG 3Y
1.29%
OPERATING MARGIN AVG 5Y
6.46%
OPERATING MARGIN AVG 10Y
17.34%
OPERATING MARGIN AVG 15Y
17.45%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+46.03%
CURRENT VS 3Y AVG
-498.60%
CURRENT VS 5Y AVG
-179.36%
CURRENT VS 10Y AVG
-129.58%
CURRENT VS 15Y AVG
-129.40%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Supernus Pharmaceuticals, Inc.
Market Cap
$2.46B
Operating Margin
-5.13%
TTM Avg
-9.51%
3Y Avg
1.29%
5Y Avg
6.46%
Market Cap
$2.52B
Operating Margin
-1002.90%
TTM Avg
-694.90%
3Y Avg
-672.96%
5Y Avg
-448.64%
Market Cap
$2.41B
Operating Margin
-0.74%
TTM Avg
-3.89%
3Y Avg
-12.55%
5Y Avg
-17.88%
Market Cap
$2.41B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.40B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.36B
Operating Margin
42.26%
TTM Avg
35.06%
3Y Avg
13.24%
5Y Avg
-28.82%
Market Cap
$2.57B
Operating Margin
1.90%
TTM Avg
1.29%
3Y Avg
0.61%
5Y Avg
-2.83%
Market Cap
$2.34B
Operating Margin
-340.16%
TTM Avg
-365.34%
3Y Avg
-352.03%
5Y Avg
-361.50%
Market Cap
$2.33B
Operating Margin
15.25%
TTM Avg
15.68%
3Y Avg
15.36%
5Y Avg
13.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.46B | -5.13% | -9.51% | 1.29% | 6.46% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.52B | -1002.90% | -694.90% | -672.96% | -448.64% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | -0.74% | -3.89% | -12.55% | -17.88% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Disc Medicine, Inc. (IRON)vs › | $2.40B | 0.00% | 0.00% | 0.00% | 0.00% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 42.26% | 35.06% | 13.24% | -28.82% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 1.90% | 1.29% | 0.61% | -2.83% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.34B | -340.16% | -365.34% | -352.03% | -361.50% |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 15.25% | 15.68% | 15.36% | 13.51% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | -274.57% | -464.41% | -382.79% | -92575.80% |
Gross Margin
88.1%
Operating Margin
-5.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -26.46% |
| 2026-03-31 | -3.58% |
| 2025-12-31 | 6.53% |
| 2025-09-30 | -31.35% |
| 2025-06-30 | 7.34% |
| 2025-03-31 | -6.85% |
| 2024-12-31 | 12.29% |
| 2024-09-30 | 23.25% |
| 2024-06-30 | 13.41% |
| 2024-03-31 | -2.20% |
| 2023-12-31 | -0.61% |
| 2023-09-30 | 5.29% |
| 2023-06-30 | -12.97% |
| 2023-03-31 | 3.37% |
| 2022-12-31 | 20.52% |
| 2022-09-30 | -0.86% |
| 2022-06-30 | 6.67% |
| 2022-03-31 | 1.29% |
| 2021-12-31 | 3.83% |
| 2021-09-30 | 21.96% |
| 2021-06-30 | 24.14% |
| 2021-03-31 | 10.09% |
| 2020-12-31 | 29.95% |
| 2020-09-30 | 36.19% |
| 2020-06-30 | 35.94% |
| 2020-03-31 | 30.55% |
| 2019-12-31 | 40.63% |
| 2019-09-30 | 38.90% |
| 2019-06-30 | 40.69% |
| 2019-03-31 | 29.75% |
| 2018-12-31 | 34.38% |
| 2018-09-30 | 36.38% |
| 2018-06-30 | 35.89% |
| 2018-03-31 | 34.72% |
| 2017-12-31 | 38.84% |
| 2017-09-30 | 27.79% |
| 2017-06-30 | 34.38% |
| 2017-03-31 | 29.16% |
| 2016-12-31 | 26.13% |
| 2016-09-30 | 34.92% |
| 2016-06-30 | 20.71% |
| 2016-03-31 | 12.35% |
| 2015-12-31 | 16.06% |
| 2015-09-30 | 11.17% |
| 2015-06-30 | 8.78% |
| 2015-03-31 | 12.19% |
| 2014-12-31 | 15.35% |
| 2014-09-30 | 55.57% |
| 2014-06-30 | 12.66% |
| 2014-03-31 | -147.80% |
| 2013-12-31 | -109.90% |
| 2013-09-30 | -1366.35% |
| 2013-06-30 | -5508.54% |
| 2013-03-31 | -12182.31% |
| 2012-12-31 | -1169.17% |
| 2012-09-30 | -13505.49% |
| 2012-06-30 | -10172.53% |
| 2012-03-31 | -3787.50% |
| 2011-12-31 | 204.47% |
| 2011-09-30 | -90136.36% |
| 2011-06-30 | -1119.47% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 224.74% |
| 2010-09-30 | 0.00% |
| 2009-12-31 | 267.37% |
